<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Depending on the population studied, intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> accounts for 10% to 29% of ischemic brain events </plain></SENT>
<SENT sid="1" pm="."><plain>A significant number of patients with intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> continue to suffer from repeated <z:hpo ids='HP_0001297'>strokes</z:hpo> or <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> despite optimal medical management </plain></SENT>
<SENT sid="2" pm="."><plain>In selected patients, intracranial angioplasty with or without stenting is a promising treatment option </plain></SENT>
<SENT sid="3" pm="."><plain>Patient selection, careful periprocedural medical management, and a highly skilled neuroendovascular interventionalist are required in order to perform the procedure with an acceptable risk </plain></SENT>
</text></document>